Investing

Zoom Video stock price has held steady in the past few years as its growth trajectory waned after the COVID-19 boom. ZM was trading at $90, inside a range it has remained at in the…

Alphabet stock traded lower on Monday, in line with broader market weakness, as investors continued to assess the company’s aggressive artificial intelligence investment plans.The parent company of Google and YouTube has delivered strong gains over…

CrowdStrike Holdings Inc (NASDAQ: CRWD) has crashed nearly 25% this month as Anthropic’s launch of “Claude Code Security” triggered a massive sector-wide sell-off.Still, it’s conceivable that artificial intelligence (AI) disruption fears, at least for CRWD,…

Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder to refill, and one more item for the sharps bin.Eli Lilly is trying…

US equities were little changed on Monday after President Donald Trump announced an increase in global tariffs to 15%, following a Supreme Court ruling that struck down his earlier “reciprocal” tariff framework.The S&P 500 hovered…

Almirall, a pharmaceutical firm based in Spain, ended 2025 with a net profit of €46.2 million, which was 357% more than its 2024 profit of €10.1 million. The Barcelona-based pharmaceutical company was able to exceed…

Vanda Pharmaceuticals (NASDAQ: VNDA) opened some 45% higher today after the biotech firm said it has received the FDA’s approval for its treatment of schizophrenia and bipolar I disorder.The BYSANTI (milsaperidone) announcement is a welcome…

Nvidia stock (NASDAQ: NVDA) ticked higher on Monday as Wall Street headed into the chipmaker’s Feb. 25 earnings report with expectations already sky-high.The rally came as the analysts are modeling roughly $65 billion-plus in quarterly…

In a sweeping and provocative macro-analysis titled “The 2028 Global Intelligence Crisis,” Citrini Research has outlined a sobering vision of a financial future where the very success of Artificial Intelligence becomes the primary engine of…

Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in a $7.8 billion all-cash deal.The stock’s move wasn’t a mystery rally.The surge was…